Autopsy report · NCT01048983

Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)

“No accrual.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

M.D. Anderson Cancer Center

Sponsor type

University, hospital or other

Conditions

Non Small Cell Lung Cancer

Interventions

Armodafinil; Bupropion; Minocycline; Curcumin; Telephone Questionnaire

Participants

0

Trials that died the same way

• A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer
  “No accruals” (91% match in meaning)
• Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer
  “non-accrual” (81% match in meaning)
• The Effects of Spiritual Needs on Spiritual Well-Being in Patients With Brain Tumors: A Structural Equation Modeling Approach
  “0 accrual” (78% match in meaning)
• Metabolic Response to Food in Lung Cancer
  “Poor accrual.” (78% match in meaning)
• Topical Henna Preparation for the Treatment of Hand Foot Skin Syndrome
  “No subject accrual.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.